/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Incidence and risk factors for major bleeding events in atrial fibrillation patients on direct oral anticoagulant therapy: data from the National Patient-Centered Clinical Research Network
Event: ESC Congress 2022
Topic: Oral Anticoagulation
Session: Stroke prevention in atrial fibrillation
ESC 365 is supported by
